Fig. 2From: Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”a) Biochemical relapse-free rate; b) Biochemical relapse-free rate by risk group; c) Biochemical relapse-free rate by use of ADT in intermediate-risk group patientsBack to article page